These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma. Valencia K; Sainz C; Bértolo C; de Biurrun G; Agorreta J; Azpilikueta A; Larrayoz M; Bosco G; Zandueta C; Redrado M; Redín E; Exposito F; Serrano D; Echepare M; Ajona D; Melero I; Pio R; Thomas R; Calvo A; Montuenga LM Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34870316 [TBL] [Abstract][Full Text] [Related]
6. Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas. Yamano S; Gi M; Tago Y; Doi K; Okada S; Hirayama Y; Tachibana H; Ishii N; Fujioka M; Tatsumi K; Wanibuchi H Cancer Sci; 2016 Feb; 107(2):123-32. PubMed ID: 26663681 [TBL] [Abstract][Full Text] [Related]
7. PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model. Dwyer-Nield LD; McArthur DG; Hudish TM; Hudish LI; Mirita C; Sompel K; Smith AJ; Alavi K; Ghosh M; Merrick DT; Tennis MA; Keith RL Int J Cancer; 2022 Dec; 151(12):2195-2205. PubMed ID: 35830207 [TBL] [Abstract][Full Text] [Related]
8. Xeroderma Pigmentosum Group C Deficiency Alters Cigarette Smoke DNA Damage Cell Fate and Accelerates Emphysema Development. Sears CR; Zhou H; Justice MJ; Fisher AJ; Saliba J; Lamb I; Wicker J; Schweitzer KS; Petrache I Am J Respir Cell Mol Biol; 2018 Mar; 58(3):402-411. PubMed ID: 29111769 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model. Mazzilli SA; Hershberger PA; Reid ME; Bogner PN; Atwood K; Trump DL; Johnson CS Cancer Prev Res (Phila); 2015 Oct; 8(10):895-904. PubMed ID: 26276745 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells. Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406 [TBL] [Abstract][Full Text] [Related]
11. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells. Chen JC; Ma PF; Lin YC; Wu CH; Peng YS; Zheng HY; Lin MC; Li YT; Lin YW Pharmacology; 2018; 102(1-2):91-104. PubMed ID: 29953987 [TBL] [Abstract][Full Text] [Related]
12. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597 [TBL] [Abstract][Full Text] [Related]
13. N-nitroso-tris-chloroethylurea induces premalignant squamous dysplasia in mice. Hudish TM; Opincariu LI; Mozer AB; Johnson MS; Cleaver TG; Malkoski SP; Merrick DT; Keith RL Cancer Prev Res (Phila); 2012 Feb; 5(2):283-9. PubMed ID: 22086679 [TBL] [Abstract][Full Text] [Related]
14. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress. Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170 [TBL] [Abstract][Full Text] [Related]
15. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C. Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428 [TBL] [Abstract][Full Text] [Related]
16. NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model. Zakaria MA; Rajab NF; Chua EW; Selvarajah GT; Masre SF Sci Rep; 2021 Nov; 11(1):22500. PubMed ID: 34795360 [TBL] [Abstract][Full Text] [Related]
17. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene. Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334 [TBL] [Abstract][Full Text] [Related]
18. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. Rezvani HR; Kim AL; Rossignol R; Ali N; Daly M; Mahfouf W; Bellance N; Taïeb A; de Verneuil H; Mazurier F; Bickers DR J Clin Invest; 2011 Jan; 121(1):195-211. PubMed ID: 21123941 [TBL] [Abstract][Full Text] [Related]
19. Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas. Rehm S; Lijinsky W; Singh G; Katyal SL Am J Pathol; 1991 Aug; 139(2):413-22. PubMed ID: 1651059 [TBL] [Abstract][Full Text] [Related]
20. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Yang G; Curley D; Bosenberg MW; Tsao H Cancer Res; 2007 Jun; 67(12):5649-57. PubMed ID: 17575131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]